Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer
Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer
复制标题
血小板、纤维蛋白原、中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值联合检测对肺腺鳞癌患者的预后价值
DOI：
10.3892/ol.2017.6660
复制
发表时间：
2017-10-01
期刊：
影响因子：
2.9
通讯作者：
Jiang, Ri-Cheng
中科院分区：
文献类型：
--
作者：
Wang, Yu-Qian;Zhi, Qiong-Jie;Jiang, Ri-Cheng
本研究旨在探讨联合血小板（PLT）、纤维蛋白原（FBG）、中性粒细胞与淋巴细胞比值（NLR）和血小板与淋巴细胞比值（PLR）（CO-NPF）对肺腺鳞癌（ASC）患者术后预后的预测价值。回顾性分析了2005年1月至2013年12月期间在天津医科大学附属肿瘤医院就诊的患者的检查结果。根据PLT、FBG、NLR和PLR的增加，CO-NPF评分在0到4之间，然后根据存在（>= 2）或不存在（
The aim of the present study was to investigate the prognostic value of the combined platelet (PLT), fibrinogen (FBG), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) (CO-NPF) for postoperative outcomes in patients with lung adenosquamous cancer (ASC). Test results from patients who presented at The Cancer Institute and Hospital of Tianjin Medical University between January 2005 and December 2013 were retrospectively reviewed. CO-NPF was scored between 0 and 4 according to increased PLT, FBG, NLR and PLR prior to being split into two groups based on the presence (>= 2) or absence (